EIGHTEENTH CONGRESS OF THE 
REPUBLIC OF THE PHILIPPINES 
Second Regular Session
)
SENATE 
S. No. 2022
E-FILED
Iu5 r>A TFT January 26 2021 tTtj 
|C0 
TW.1P»J..0:51 am
ey
NDEX
Introduced by SENATOR RAMON BONG REVILLA, JR.
AN ACT
ESTABLISHING THE GOVERNMENT VACCINE INDEMNIFICATION 
PROGRAM, PROVIDING FUNDS THEREFOR, AND FOR OTHER PURPOSES
EXPLANATORY NOTE
Article II, Section 15 of the Philippine Constitution states that, "The State shall 
protect and promote the right to health of the people and instill health consciousness 
among them."
While there are many approaches to providing health services to our people, 
the principle that "prevention Is better than cure" has always been at the core of our 
health system such that, among others. Republic Act No. 7846 or the law on 
Compulsory Immunization Against Hepatitis-B, and Republic Act No. 10152, otherwise 
known as the "Mandatory Infants and Children Health Immunization Act of 2011" were 
enacted into law to ensure the government's proactive role in the preventive health 
care of infants and children.
According to the 2011 Family Health Survey (FHS) of the Philippine Statistics 
Authority, the percentage of Filipino children 12-23 months old who received six (6) 
basic vaccinations was at 90.9%. However, to sustain this rate is a great challenge 
to the government. For instance, poliovirus, a highly infectious but vaccine- 
preventable disease, was totally eradicated in the country in the year 2000 but the


Department of Health declared a polio outbreak in the country on September 19,2020. 
This was attributed to a decline of immunization coverage In the past few years. 
Moreover, according to the World Health Organization, a study from the London 
School of Hygiene and Tropical Medicine revealed that Filipinos who believe "that 
vaccines are important, are safe and are effective" declined from almost 100% in 2015 
to 60-80% in 2018 because of the Issue on dengue vaccine.
The COVID-19 pandemic Is the most recent challenge that ravaged the entire 
international community. Now that the vaccine against the virus is available and is 
continuously being studied, there is no certainty if the target population will indeed be 
going to the vaccination sites to be inoculated. In a survey conducted by the Social 
Weather Stations from September 17-20, 2020 with 1,249 respondents nationwide, 
66% said that they are willing to get the COVID-19 vaccine. On the other hand, in a 
survey conducted by the Pulse Asia from November 23 to December 2, 2020 from 
among 2,400 Filipino adults, only 32% said they are willing to be inoculated. Another 
survey which is conducted by OCTA Research from December 9-13, 2020 with 600 
respondents from Metro Manila revealed that only 25% are willing to be inoculated. 
The reasons for their hesitance varies, but confidence on the effectivity and safety of 
the vaccine is a primary concern.
This measure proposes the creation of the Government Vaccine Indemnification 
Fund which shall be exclusively used to compensate and indemnify identified vaccine 
recipients who sustained injury and experienced adverse effects due to the 
vaccination. The Fund will be sourced from the 1% of the contract price of all 
pharmaceutical companies participating in public tenders and awarded government 
contracts for the supply of such vaccines.
The bill Intends to protect both the vaccine manufacturers and the public. 
Through the Fund, the governrhent expects to reduce the apprehension and 
reluctance of the vaccine manufacturers and suppliers because of the fear of possible 
court cases and related negative effects to their product and company. At the same


time, it aims to restore the confidence of the people to the vaccines and the related 
assistance that the government wiii provide them.
This legislative measure is initially a response to the call of the Department of 
Health to establish such a fund in relation to the COVID-19 vaccine. But beyond this, 
it hopes to strengthen the country's health system, and promote our people's safety 
and protection.
In light of the aforementioned, the immediate passage of this bili is highly 
recommended.
RAMO^ONG REVILLA, JR.


EIGHTEENTH CONGRESS OF THE 
REPUBLIC OF THE PHILIPPINES 
Second Regular Session
)
SENATE 
S. No. 2022
lit PTX 
1HE
E-FLED
January 26 2021 Hr
date:
TW.1P',10:51 am
NOb X
BILLS
Introduced by SENATOR RAMON BONG REVILLA, JR.
AN ACT
ESTABLISHING THE GOVERNMENT VACCINE INDEMNIFICATION 
PROGRAM, PROVIDING FUNDS THEREFOR, AND FOR OTHER PURPOSES
Be it enacted by the Senate and House of Representative of the Philippines in Congress 
assembled:
1 
Section 1. Short Title. - This Act shall be known as the " Vaccine Indemnification
2 
Fund Act'.
3 
Sec. 2. Declaration of Policy. - It is a policy of the State to protect and promote
4 
the right to heaith of the people and instill health consciousness among them.
5 
Likewise, it is the State's responsibility to establish and maintain an effective drug
6 
regulatory system and undertake appropriate policies that are responsive to the
7 
country's health needs and problems.
8 
Consistent with this Constitutional mandate, the State shall implement a system
9 
for vaccine-related injury indemnification to serve as a fair, efficient and stable
10 
mechanism for individuals to obtain compensation upon the occurrence of verified
11 
vaccine-related adverse events without need to attribute fauit or negligence on
12 
vaccine manufacturers or supplier. This shall be the primary mode of compensation
13 
and as an alternative to long-drawn, expensive court litigations that constrain vaccine
14 
recipients from pursuing bona fide claims for vaccine-related injuries.
15 
Sec. 3. Sources of the Fund.—The Government Vaccine Indemnification Fund,
16 
hereinafter referred to as the "Fund", shall be subsidized by pharmaceutical companies
17 
that supply the government with vaccines for public immunization programs.


1 
Pharmaceutical companies participating in public tenders and are awarded
2 
government contracts for the supply of such vaccines shali reserve at least one percent
3 
(1%) of the contract price which shall form part of the Fund. The reserved amount
4 
shall be deposited with the Bureau of the Treasury of the Department of Budget and
5 
Management (DBM).
6 
Sec. 4. Use of Fund. - The Fund shall be earmarked exclusively to compensate
7 
and indemnify identified vaccine recipients who sustain injury In connection with the
8 
use of the vaccines and where the adverse effects are attributable to the vaccination
9 
Sec. 5. Management of the Fund. - The Fund shall be managed by the Vaccine
10 
Compensation Board, hereinafter referred to as the "Board", composed of the
11 
following:
12 
1) Secretary of Justice-Chairperson
13 
2) Secretary of Health - Vice-Chairperson
14 
3) Secretary of Budget and Management - Member
15 
4) Secretary of Finance - Member
16 
5) Sectoral representative from the healthcare industry - Member
17 
6) Sectoral representative from the patient advocacy groups - Member
18 
7) Sectoral representative from the medical societies - Member
19 
The sectoral representatives shall have a term of office of three (3) years. The
20 
President of the Philippines shall appoint from among a list of three (3) candidates
21 
upon the favorable recommendation by the organizations of their respective sectors.
22 
Upon approval of this Act, the sectoral representative from the healthcare industry
23 
shall have an initial term of one (1) year and the sectoral representative from patient
24 
advocacy groups shall have an initial term of two (2) years. Thereafter, the three-
25 
year term shall apply to all subsequent appointments. No sectoral representative who
26 
has served a full term shall be eligible for reappointment to the Board.
27 
Sec. 6. Powers and Functions of the Board. - The Board shall have the
28 
following powers and functions:
29 
(a) Provide overall strategic direction and guidance in the implementation of
30 
this Act including but not limited to the administration and utilization of
31 
the Fund, eligibility requirements, rules on filing claims for injury or death


1 
and the decision-making process, standard of proof required, elements
2 
of compensation and litigation rights of the parties involved;
3 
(b) Exercise original and exclusive jurisdiction on verified bona fide claims
4 
for compensation or Indemnification on vaccine-related Injuries or death;
5 
(c) Establish an efficient system for reporting and periodic reviews on the
6 
use and management of the Fund through stringent internal controls
7 
and Information systems; and,
8 
(d) Such other powers as may be proper and necessary to perform their
9 
duties and responsibilities effectively and with full transparency taking
10 
Into consideration the nest interests of all relevant stakeholders.
11 
Sec. 7. Appropriations. — The amount needed for the initial implementation of
12 
this Act shall be charged against the appropriations of the Department of Health (DOH)
13 
in the current and subsequent General Appropriations Act. Thereafter, the amount
14 
needed for the continued implementation of this Act shall be taken from the Fund. In
15 
case the Fund, after careful assessment and projected utilization, shall be insufficient
16 
to answer for potential claims, the DOH shall subsidize such amount in the
17 
supplemental budget to be Included in the annual General Appropriations.
18 
Sec. 8. Impiementing Ruies and Reguiations. - Within six (6) months from the
19 
approval of this Act, the Department of Justice (DOJ), the DOH, the DBM and the
20 
Department of Finance (DOF) in coordination with other implementing agencies, shall
21 
formulate rules and guidelines as may be necessary for the proper implementation
22 
and enforcement of this Act.
23 
Sec. 9. Separabiiity Ciause. - If any provision or part hereof is held invalid or
24 
unconstitutional, the remainder of the law or the provision or part not otherwise
25 
affected shall remain valid and subsisting.
26 
Sec. 10. Repeaiing Ciause. - Any law, presidential decree or issuance,
27 
executive order, letter of instruction, administrative order, rule, or regulation contrary
28 
to or inconsistent with the provisions of this Act are hereby repealed, modified, or
29 
amended accordingly.
30 
Sec. 11. Effectivity. - This Act shall take effect fifteen (15) days after its
31 
publication in the Officiai Gazette or in a newspaper of general circulation.
32 
Approved,